RICHARD KELL: Open Payments
NPI 1326737453 · NEW CUMBERLAND, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 48 payments from 21 companies in 2025. Trend: 2023 $164 · 2024 $28 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $136 |
| GlaxoSmithKline, LLC. | 6 | $104 |
| Lilly USA, LLC | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| PFIZER INC. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $39 |
| Amgen Inc. | 2 | $34 |
| Viatris Specialty LLC | 1 | $29 |
Products named: TRELEGY ELLIPTA, FANAPT, Wegovy, Rybelsus, MOUNJARO, Symbravo, NURTEC ODT, KISUNLA.
Industry payments across PA — which companies pay providers there.
